Immunogenicity of recurrent mutations in MYD88 and EZH2 in non-Hodgkin lymphomas
Main Authors: | Nielsen, Julie S, Chang, Andrew R, Wick, Darin A, Sedgwick, Colin G, Zong, Zusheng, Mungall, Andrew J, Baraki, Bemuluyigza, Kinloch, Natalie, Brumme, Zabrina L, Treon, Steven P, Connors, Joseph M, Gascoyne, Randy D, Webb, John R, Berry, Brian R, Morin, Ryan D, Macpherson, Nicol, Nelson, Brad H |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652530/ |
Similar Items
-
A MyD88 meddles with survival
by: Bashyam, Hema
Published: (2007) -
Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation
by: Livraghi-Butrico, Alessandra, et al.
Published: (2012) -
Alternative activation of macrophages by filarial nematodes is MyD88-independent
by: Mylonas, Katie J., et al.
Published: (2013) -
Synergy between CD40 and MyD88 Does Not Influence Host Survival to Salmonella Infection
by: Wenzel, Ulf Alexander, et al.
Published: (2015) -
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
by: Silasi, Dan-Arin, et al.
Published: (2007)